LFUS irradiation was carried out if required
Over time, potential benefits may include continued fat loss, improved metabolic health, better weight maintenance, and greater confidence and quality of life
The SURPASS trial program showed A1C reductions of up to 2.3% with tirzepatide 15 mg, which is exceptional
Deterioration of CD was classified according to the CD activity index (CDAI) (34), which is a composite scoring system based on selected clinical symptoms, such as the number of liquid stools, the severity of abdominal pain, general well-being, extraintestinal CD manifestations, abdominal mass, use of antidiarrheal drugs, as well as haematocrit and body weight
The company also claims millions of appointments, hundreds of payer relationships, referrals from 250+ health systems, and 200M+ covered lives